Marie-Louise Vachon
Chercheuse associée
Axe Maladies infectieuses et immunitaires
Publications
Voir tout-
article Walmsley SL, Lovblom LE, Boyachuk B, Cooper C, Martel-Laferrière V, Loutfy M, Vachon ML, Haider S, Aldebes P, Colwill K, Gingras AC, Qi F, Klein MB
SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIV
Antibodies (Basel) 15 (2), 2026.
-
article Mitha E, Ferguson M, Wilhase AC, De Looze F, Vachon ML, Stacey H, Rasalam R, Nozaki M, Smith WB, Schwarz TF, Hailemariam HA, Deraedt Q, Gérard C, Vanden Abeele C, Damaso S, Descamps D, Hill J, Dasyam D, Van Gucht J, Hulstrøm V
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compar…
Clin Infect Dis 82 (5), 2026.
-
article Elakpa DN, Lawton D, Tooley TH, van Rooyen K, Bruneau J, Cooper C, Dickie M, Feld JJ, Janjua NZ, King A, Kronfli N, Presseau J, Wilson J, Vachon ML, Fontaine G, On Hepatitis C CanHepC OBOTCN
The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations
Can Liver J 8 (4), 2025.
Projets
- A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV, du 2022-10-01 au 2027-09-30
- A Phase 2,Multicenter,Randomized,Double-Blind,Placebo-controlled Study to Evaluate Efficacy,Safety,Tolerability,and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral [...], du 2024-03-28 au 2029-12-25
- After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada, du 2023-04-01 au 2027-03-31
- Building Capacity in Innovative Adaptive Trial Designs for HIV and STBBI Research: The CTN-Québec Training Platform, du 2025-10-01 au 2029-09-30
- Surveillance des réponses immunitaires au vaccin contre la COVID-19 chez les personnes vivant avec le VIH-1, du 2021-12-01 au 2025-03-31
- Optimiser le dépistage des populations vulnérables par goutte de sang séché, du 2022-01-15 au 2024-10-15